TrademarkDir
SPOKEN RX
LIVE

Serial Number

88830224

Owner

CVS PHARMACY, INC.

Attorney

Erich G. Rhynhart

First Use Date

May 19, 2020

Filing Date

Mar 11, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SPOKEN RX Trademark

Serial Number: 88830224 • Registration: 6715031

SPOKEN RX is a trademark filed by CVS PHARMACY, INC. on March 11, 2020. The trademark is classified under Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

CVS PHARMACY, INC. (1,090 trademarks)

WOONSOCKET, RI 02895

Entity Type: 03

Trademark Details

Filing Date

March 11, 2020

Registration Date

May 3, 2022

First Use Anywhere

May 19, 2020

First Use in Commerce

May 19, 2020

Published for Opposition

February 15, 2022

Goods & Services

Downloadable software component in the nature of a mobile application feature for use to assist users in reading instructions, directions and warnings for medical equipment, medical devices and pharmaceuticals for visually impaired users sold as an integral component of the software

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 30, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 30, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 30, 2024 REAP
REGISTERED-PRINCIPAL REGISTER
May 3, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 26, 2022 NONP
EXPARTE APPEAL TERMINATED
Jan 12, 2022 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2021 TROA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Jul 15, 2021 AAUA
USE AMENDMENT ACCEPTED
Jul 14, 2021 IUAA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 14, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2021 CRFA
AMENDMENT TO USE PROCESSING COMPLETE
Jul 2, 2021 AUPC
ASSIGNED TO LIE
Jul 2, 2021 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 21, 2021 ERFR
EX PARTE APPEAL-INSTITUTED
Jun 21, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 21, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jun 21, 2021 EXAF
USE AMENDMENT FILED
May 24, 2021 IUAF
TEAS AMENDMENT OF USE RECEIVED
May 24, 2021 EAAU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 18, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 18, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 18, 2021 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 21, 2020 GNFN
FINAL REFUSAL E-MAILED
Dec 21, 2020 GNFR
FINAL REFUSAL WRITTEN
Dec 21, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 8, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 4, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2020 NWOS
NEW APPLICATION ENTERED
Mar 14, 2020 NWAP

Related Trademarks

More from this Owner

ATTAIN HEALTH

ATTAIN HEALTH

ATTAIN HEALTH

ATTAIN HEALTH

ATTAIN HEALTH

ATTAIN HEALTH

MIND COMPANION

MIND COMPANION

MIND COMPANION

MIND COMPANION

MIND COMPANION

MIND COMPANION